Akern invests in Jatreia to strengthen its position in the Italian body composition measurement market by leveraging Jatreia's distribution network.
Information on the Target
Akern is a leading international company specializing in the development of body composition measurement solutions utilizing bioelectrical impedance technology. Currently under the ownership of Red Lions SpA, Akern is committed to expanding its commercial structure by acquiring a strategic stake in Jatreia Srl. This collaboration will empower Jatreia to promote and distribute Akern's innovative solutions within the private sector in Italy.
Founded in 2015 by CEO Fabiano Merzari, Jatreia has demonstrated robust growth over the past few years, driven by a strong customer-oriented approach and ongoing training initiatives that encompass both technical and scientific aspects. The partnership with Akern is set to enhance Jatreia's capabilities in delivering high-quality measurement solutions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Italy
The market for body composition measurement solutions in Italy has been experiencing significant growth, driven by increasing health awareness among consumers and the rising demand fo
Similar Deals
NTC s.r.l. → Formycon’s Eylea® biosimilar FYB203/Baiama®
2025
Antin Infrastructure Partners → Hippocrates
2021
Boston Scientific → Nalu Medical
2026
Barça Innovation Hub → Omniscope
2025
Akern
invested in
Jatreia Srl
in 2019
in a Strategic Partnership deal